Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation

This publication has 12 references indexed in Scilit:

• Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy
  The Journal of Heart and Lung Transplantation, 2010
• Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
  The Journal of Heart and Lung Transplantation, 2010
• Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
  Published by Elsevier ,2010
• Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants
  The Journal of Heart and Lung Transplantation, 2010
• Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
  New England Journal of Medicine, 2009
• Rise of the Machines — Left Ventricular Assist Devices as Permanent Therapy for Advanced Heart Failure
  New England Journal of Medicine, 2009
• Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulation
  The Journal of Heart and Lung Transplantation, 2009
• Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist Device
  Published by Elsevier ,2009
• INTERMACS Profiles of Advanced Heart Failure: The Current Picture
  Published by Elsevier ,2009
• Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
  New England Journal of Medicine, 2007